Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ventyx Biosciences Inc.

    NASDAQ: VTYX · Real-Time Price · USD
    2.54
    -0.02 (-0.78%)
    At close: Jun 16, 2025, 3:59 PM
    2.54
    -0.20%
    After-hours: Jun 16, 2025, 07:20 PM EDT

    Ventyx Biosciences Statistics

    Share Statistics

    Ventyx Biosciences has 71.16M shares outstanding. The number of shares has increased by 0.89% in one year.

    Shares Outstanding

    n/a
    		 71.16M

    Shares Change (YoY)

    n/a
    		 0.89%

    Shares Change (QoQ)

    n/a
    		 0.59%

    Owned by Institutions (%)

    n/a
    		 77.05%

    Shares Floating

    n/a
    		 63.06M

    Failed to Deliver (FTD) Shares

    n/a
    		 173

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 6.74M, so 9.46% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.74M

    Short % of Shares Out

    n/a
    		 9.46%

    Short % of Float

    n/a
    		 10.06%

    Short Ratio (days to cover)

    n/a
    		 3.39

    Valuation Ratios

    The PE ratio is -1.11 and the forward PE ratio is -1.35. Ventyx Biosciences's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -1.11

    Forward PE

    n/a
    		 -1.35

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 0.59

    P/FCF Ratio

    n/a
    		 -1.14

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Ventyx Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 17.97, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 17.97

    Quick Ratio

    n/a
    		 17.97

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.08

    Debt / FCF

    n/a
    		 -0.08

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,668,172.84

    Employee Count

    n/a
    		 81

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -7.64% in the last 52 weeks. The beta is 0.85, so Ventyx Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.85

    52-Week Price Change

    n/a
    		 -7.64%

    50-Day Moving Average

    n/a
    		 1.52

    200-Day Moving Average

    n/a
    		 1.9

    Relative Strength Index (RSI)

    n/a
    		 71.48

    Average Volume (20 Days)

    n/a
    		 1,426,047

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -148.45M

    Net Income

    n/a
    		 -135.12M

    EBITDA

    n/a
    		 -133.77M

    EBIT

    n/a
    		 -135.12M

    Earnings Per Share (EPS)

    n/a
    		 -1.97
    Full Income Statement

    Balance Sheet

    The company has 27.26M in cash and 10.79M in debt, giving a net cash position of 16.47M.

    Cash & Cash Equivalents

    n/a
    		 27.26M

    Total Debt

    n/a
    		 10.79M

    Net Cash

    n/a
    		 16.47M

    Retained Earnings

    n/a
    		 -554.31M

    Total Assets

    n/a
    		 253.48M

    Working Capital

    n/a
    		 230.16M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -130.87M and capital expenditures -241K, giving a free cash flow of -131.11M.

    Operating Cash Flow

    n/a
    		 -130.87M

    Capital Expenditures

    n/a
    		 -241K

    Free Cash Flow

    n/a
    		 -131.11M

    FCF Per Share

    n/a
    		 -1.91
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    VTYX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for VTYX is $11, which is 333.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $11

    Price Target Difference

    n/a
    		 333.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.37

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist